UPDATE: Truist Securities Starts Affimed Therapeutics (AFMD) at Buy
Tweet Send to a Friend
(Updated - October 21, 2021 6:15 AM EDT)
Truist Securities analyst Srikripa Devarakonda initiates coverage on Affimed Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Srikripa Devarakonda initiates coverage on Affimed Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
